African-American Heart Failure Trial

Nitromed13 个研究点分布在 1 个国家目标入组 1,100 人开始时间: 2001年5月1日最近更新: 2005年6月24日

适应症

试验速览

阶段: 4 期
状态: 已完成
发起方: Nitromed
入组人数: 1,100
试验地点: 13

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

详细描述

The overall objective is confirmation of BiDil's Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Single Group
主要目的: Treatment
盲法: Double

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•African American male or female 18 years or older.
•NYHA Class 3 &
•Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).

排除标准

未提供

研究者

发起方

Nitromed

申办方类型

Industry

研究点 (13)

Loading locations...

相似试验

已完成

不适用

Intervention by a Cardiologist and Geriatrician in Elderly Patients After Admission Due to Heart Failure.Heart Failure

NCT03555318Parc de Salut Mar150

Unknown

4 期

Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron DeficiencyIron-deficiencyChronic Heart Failure

NCT03344523Lee's Pharmaceutical Limited600

已完成

2 期

Ranolazine in Diastolic Heart FailureDiastolic Heart Failure

NCT01163734Gilead Sciences20

Unknown

3 期

Sildenafil in US Heart Failure Patients (SilHF-US)Heart FailurePulmonary Hypertension

NCT03460470Hartford Hospital25

招募中

1 期

Beta-blocker Administration for Cardiomyocyte DivisionTetralogy of FallotDouble Outlet Right Ventricle

NCT04713657Weill Medical College of Cornell University40